Research · 5 min read
How research institutions monetize their patent portfolios
The short answer: Research institutions often hold hundreds of IP rights, many of which go unused yet still incur fees. Systematic, software-assisted screening shows which families have licensing, sale or enforcement potential – often with partners beyond the obvious industry. With a success-based model, this happens without any burden on the institution's budget.
The problem: many IP rights, little capacity
Universities and research institutes file new inventions continuously. Over the years, this produces large portfolios with hundreds of patent families – from completed projects, from collaborations, from basic research whose applications only become visible later.
Monetization capacity does not grow at the same pace. Technology transfer offices take care of current projects, spin-offs and ongoing agreements. There is usually no time for a systematic review of the entire portfolio. The result: many IP rights remain unused.
Unused patents cost money
A patent nobody uses is not a neutral item. Renewal fees keep running, separately in each country, plus costs for representation and deadline management. At some point, the question arises: maintain or abandon? Without a reliable assessment of market potential, that decision is often made on gut feeling or budget pressure – and valuable families are lost.
A systematic analysis brings clarity: it shows which families are worth maintaining, which can be actively monetized and where abandoning them is a reasonable choice. Fees are then spent where there is real potential.
Systematic screening instead of case-by-case analysis
The key is to look at the whole. Instead of assessing individual inventions one after another, the entire portfolio is analyzed with software support. TYR proceeds in four steps:
1. Portfolio screening
Software-assisted analysis of the entire portfolio: active fields, market relevance, notable citations. Proprietary analysis tools enable mapping and market matching even across hundreds of families.
2. Prioritization
Which families carry weight? The IP rights are clustered by licensing potential, indications of use by third parties and market size. This shows where further work pays off – and where it does not.
3. Partner search
For the prioritized families, TYR identifies and approaches licensees and buyers – including outside the obvious industry.
4. Closing
TYR supports the negotiation through to the license or purchase agreement. If the analysis reveals indications of infringement, enforcement with funding is optionally possible.
Three routes to monetization
Licensing
For research institutions, licensing is often the most natural route: the institution remains the owner, a company receives rights of use, and revenue is generated that can flow back into research.
Sale
If an IP right no longer fits the institution’s profile, a sale can make sense – to a company that uses the technology, or to a specialized monetization company. Future fees are then no longer incurred.
Enforcement
If a company is already using a patented technology without a license, an enforceable claim may exist; its legal assessment is provided by specialized law firms. With litigation funding, the institution bears no cost risk. Often, the robust preparation of such a case alone leads to a licensing solution.
Licensees beyond the obvious
The obvious candidates – collaboration partners, well-known competitors in the field – are usually already known to the transfer office. The greatest potential, however, often lies in non-obvious fields of application: a process from materials research may be relevant to an entirely different industry, a measurement method to a sector nobody had on their radar.
Software-assisted analyses help find such connections – for example through companies active in related technical fields, or through third-party filings that build on the institution’s own portfolio. Licensing partners need not be infringers; often they are companies that would simply benefit from the technology.
Success-based, with no burden on budgets
Research budgets are committed, and monetization projects with an uncertain outcome are hard to pre-finance. That is why TYR works on a purely success-based model: screening and analysis are free of charge, and TYR is only paid if successful, through a share of license or sale proceeds. For the institution, that means 0 € burden on the budget.
TYR sees itself as a complement to the transfer office, not a replacement: additional capacity for systematic analysis, market access to licensees and funders, and support with enforcement where there are indications of infringement.
From practice
In a current project, TYR systematically analyzed the large portfolio of a research institution: software-assisted screening, prioritization of the viable families and identification of licensing partners, including outside the obvious fields of application.
For an initial assessment, an overview of the portfolio – or just the name of your institution – is enough. Legal advice, for instance on contract drafting or enforcement, is provided by specialized law firms and patent attorneys, which TYR coordinates on request.
This article is for general information and is not legal advice.